Research / ACA / Fundamental state Inspectable configuration
State dimensions Filing 0001739445-22-000034 General Corporate
Debt relative to revenue 86th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.debt_to_revenue
124.37% · OPTIONAL · VALID
Capex intensity 85th Own-history percentile · N=13
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.83% · OPTIONAL · VALID
Operating cash generation 15th Own-history percentile · N=13
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
4.57% · OPTIONAL · VALID
Revenue growth 100th Own-history percentile · N=10
Evidence method Yoy · gp.fundamentals.revenue
21.66% · CORE · VALID
Inventory pressure 64th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
63.98% · OPTIONAL · VALID
Operating margin 29th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.operating_margin
6.48% · CORE · VALID
SBC intensity 36th Own-history percentile · N=14
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.82% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 28 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/8 normalized Level 3 Sep 30, 2025 7/8 normalized Level 3 Dec 31, 2025 7/8 normalized Level 3 Mar 31, 2026 7/8 normalized Level 3 Jun 30, 2026 7/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 32.64%
Current 124.37%
Delta 91.73% Capex Intensity Increased
Previous 4.18%
Current 4.83%
Delta 0.65% Cash Generation Decreased
Previous 8.18%
Current 4.57%
Delta -3.60% Growth Increased
Previous 5.21%
Current 21.66%
Delta 16.45% Inventory Pressure Increased
Previous 15.93%
Current 63.98%
Delta 48.04% Profitability Increased
Previous 5.27%
Current 6.48%
Delta 1.21% Sbc Intensity Decreased
Previous 0.88%
Current 0.82%
Delta -0.06% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.